On the other hand, glucagon-like peptide-1 receptor agonists (GLP-1RAs) represent a newer group of medications used to treat obesity, showing significant potential in supporting weight loss for individuals struggling with this condition [3]. This evidence concerns the gene GLP1R and obesity disorder.